Ampicillin Injection, Powder, For Solution
Product Images NDC 51662-1560

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Ampicillin (NDC 51662-1560). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Hf Acquisition Co Llc, Dba Healthfirst, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Vial :labeling (51662 1560 Vial Labeling)

Ampicillin 2 g per vial injection powder for intravenous use label, distributed by AuroMedics Pharma LLC. The label includes usage instructions to reconstitute with sterile water and highlights the dosage strength. It also mentions storage conditions and batch/expiry fields are blank.*

FDA Label Image

Case Label (51662 1560 3 Case Labeling)

AMPICILLIN injection powder for solution, USP 2 g per vial, packaged as a case of 10 vials. The label includes the NDC 51662-1560-3 and states the vial stopper is made with natural rubber. It is for intravenous use and is manufactured by HF Acquisition Co LLC, DBA HealthFirst, located in Mukilteo, WA. The product is prescription only.*

FDA Label Image

Seriliazed Labeling (51662 1560 3 Serialized Rfid Case Labeling)

Label from AMPICILLIN injection powder for solution, strength 2 g/1, distributed by HF Acquisition Co LLC, DBA HealthFirst. The label includes a barcode, several numeric codes, and instructions to see the manufacturer's package insert. It also lists the distributor's location in Mukilteo, WA 98275.*

FDA Label Image

Pouch Labeling (51662 1660 2 Pouch Labeling)

Label for AMPICILLIN injection powder for solution, USP 2 g per vial, for intravenous use. The label includes NDC 51662-1560, lot number, expiration date, and detailed instructions for reconstitution and dosage. Manufactured by HF Acquisition Co., LLC, Mukilteo, WA 98275.*

FDA Label Image

D1 (D1)

Table presenting dosage guidelines for neonates up to 28 days postnatal age for bacterial meningitis and septicemia. It categorizes dosages by gestational age (weeks) and postnatal age (days) with specified dosages in mg/kg/day administered at different intervals (every 8 or 12 hours).*

FDA Label Image

D2 (D2)

A table presenting details for various NDCs including label claim, recommended amount of diluent, withdrawable volume, and concentration in mg/mL. The label claims range from 250 mg to 2 grams, with corresponding diluent amounts and volumes for each listed NDC, all having a concentration of 250 mg/mL.*

FDA Label Image

D3 (D3)

Table outlining the stability periods of Ampicillin injection powder for solution when mixed with various diluents at room temperature (25°C) and refrigerated conditions (4°C). It lists different diluents including Sterile Water, Sodium Chloride Injection, Dextrose Injection, and Lactated Ringer's Injection with their respective concentrations and recommended stability durations.*

FDA Label Image

Structure (Structure)

Chemical structure of ampicillin, depicting its molecular configuration with labeled atoms such as carbon, nitrogen, oxygen, sulfur, and hydrogen, including a benzene ring and carboxylate group.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.